Italchimici Overview
- Founded
-
1960

- Status
-
Acquired/Merged
- Employees
-
51

- Latest Deal Type
-
M&A
- Financing Rounds
-
5
Italchimici General Information
Description
Provider of pharmaceutical products. The company is developing pharmaceuticals in two key areas: respiratory and gastroenterology. The company's product portfolio includes, among other brands, Reuflor, Peridon, Perido Natural and Lacdigest in the gastroenterological area and Aircort and Cexidal in the respiratory area.
Contact Information
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- Via B. Crespi, 19
- 20159 Milan
- Italy
+39 02 0000 0000
Italchimici Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Italchimici Patents
Italchimici Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
DE-602005014078-D1 | Pharmaceutical composition containing formoterol and propylene glycol | Active | 19-Jan-2005 | 0000000000 | |
EP-1683518-A1 | Pharmaceutical formulation of a stable formoterol-containing propylene glycol solution for use in inhalation therapy and method of preparing it | Active | 19-Jan-2005 | 0000000000 | 0 |
EP-1683518-B1 | Pharmaceutical formulation of formoterol and propylene glycol | Inactive | 19-Jan-2005 | 0000000000 | |
ES-2325664-T3 | Pharmaceutical formulation of formoterol and propylene glycol. | Active | 19-Jan-2005 | 0000000000 | |
EP-1604657-A1 | Pharmaceutical formulation of a stable formoterol-containing solution for use in inhalation therapy and method of preparing it | Inactive | 31-May-2004 | A61K9/0078 | 0 |
Italchimici Executive Team (3)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Riccardo Baraldi | Group Chief Financial Officer, TMCI Padovan |
Italchimici Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
0000000 0000000 | Italchimici | Chairman | 000 0000 |
Italchimici Signals
Italchimici Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|